Literature DB >> 12733732

Children and the risk of fractures caused by oral corticosteroids.

T P van Staa1, C Cooper, H G M Leufkens, N Bishop.   

Abstract

Oral corticosteroids are known to increase the risk of fracture in adults, but their effects in children remain uncertain. The medical records of general practitioners in the United Kingdom (from the General Practice Research Database) were used to estimate the incidence rates of fracture of children ages 4-17 years taking oral corticosteroids (n = 37,562) and of control children taking nonsystemic corticosteroids (n = 345,748). Each child with a fracture (n = 22,846) was subsequently matched by age, sex, practice, and calendar time to one child without a fracture. The average duration of treatment was 6.4 days (median, 5 days). The risk of fracture was increased in children with a history of frequent use of oral corticosteroids; children who received four or more courses of oral corticosteroids had an adjusted odds ratio (OR) for fracture of 1.32 (95% CI, 1.03-1.69). Of the various fracture types, the risk of humerus fracture was doubled in children who received four or more courses of oral corticosteroids (adjusted OR, 2.17 [1.01-4.67]). Fracture risk was also increased among children using 30 mg prednisolone or more each day (adjusted OR for fracture, 1.24 [1.00-1.52]) and among those receiving four or more courses of oral corticosteroids (OR, 1.32 [1.03-1.69]). Children who stopped taking oral corticosteroids had a comparable risk of fracture to those in the control group. Our findings suggest that children who require more than four courses of oral corticosteroid as treatment for underlying disease are at increased risk of fracture. It is not entirely clear whether this relates directly to oral corticosteroid use or the underlying disease and its severity. Irrespective of these issues, this group of children is at increased risk of fracture.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12733732     DOI: 10.1359/jbmr.2003.18.5.913

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  64 in total

1.  Vertebral fractures despite normal spine bone mineral density in a boy with nephrotic syndrome.

Authors:  Anne Marie Sbrocchi; Frank Rauch; MaryAnn Matzinger; Janusz Feber; Leanne M Ward
Journal:  Pediatr Nephrol       Date:  2010-10-05       Impact factor: 3.714

2.  Childhood onset arthritis is associated with an increased risk of fracture: a population based study using the General Practice Research Database.

Authors:  J M Burnham; J Shults; R Weinstein; J D Lewis; M B Leonard
Journal:  Ann Rheum Dis       Date:  2006-04-20       Impact factor: 19.103

3.  Vertebral compression fractures during chemotherapy for childhood acute lymphoblastic leukemia: commentary on a report from the STeroid Associated Osteoporosis in the Pediatric Population (STOPP) research program.

Authors:  Kirsten K Ness; Wassim Chemaitilly; Sue C Kaste
Journal:  Transl Pediatr       Date:  2012-10

Review 4.  A systematic review and meta-analysis of glucocorticoid-induced osteoporosis in children.

Authors:  Karen E Hansen; Brian Kleker; Nasia Safdar; Christie M Bartels
Journal:  Semin Arthritis Rheum       Date:  2014-02-11       Impact factor: 5.532

5.  Skeletal findings in children recently initiating glucocorticoids for the treatment of nephrotic syndrome.

Authors:  J Feber; I Gaboury; A Ni; N Alos; S Arora; L Bell; T Blydt-Hansen; C Clarson; G Filler; J Hay; D Hebert; B Lentle; M Matzinger; J Midgley; D Moher; M Pinsk; F Rauch; C Rodd; N Shenouda; K Siminoski; L M Ward
Journal:  Osteoporos Int       Date:  2011-04-15       Impact factor: 4.507

Review 6.  Asthma and Medicines - Long-Term Side-Effects, Monitoring and Dose Titration.

Authors:  Satnam Kaur; Varinder Singh
Journal:  Indian J Pediatr       Date:  2018-01-06       Impact factor: 1.967

Review 7.  Zoledronic acid in pediatric metabolic bone disorders.

Authors:  Sasigarn A Bowden; John D Mahan
Journal:  Transl Pediatr       Date:  2017-10

8.  Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: general therapy.

Authors:  Yoshitsugu Kaku; Yasufumi Ohtsuka; Yasuhiro Komatsu; Toshiyuki Ohta; Takuhito Nagai; Hiroshi Kaito; Shuji Kondo; Yohei Ikezumi; Seiji Tanaka; Shinsuke Matsumoto; Mayumi Sako; Kazushi Tsuruga; Koichi Nakanishi; Koichi Kamei; Hiroshi Saito; Shuichiro Fujinaga; Yuko Hamasaki; Hiroko Chikamoto; Kenji Ishikura; Kazumoto Iijima
Journal:  Clin Exp Nephrol       Date:  2015-02       Impact factor: 2.801

9.  Official positions of the International Society for Clinical Densitometry (ISCD) on DXA evaluation in children and adolescents.

Authors:  Maria Luisa Bianchi; Sanford Baim; Nick J Bishop; Catherine M Gordon; Didier B Hans; Craig B Langman; Mary B Leonard; Heidi J Kalkwarf
Journal:  Pediatr Nephrol       Date:  2009-07-15       Impact factor: 3.714

10.  The epidemiology of osteonecrosis: findings from the GPRD and THIN databases in the UK.

Authors:  C Cooper; M Steinbuch; R Stevenson; R Miday; N B Watts
Journal:  Osteoporos Int       Date:  2009-06-23       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.